• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于区分神经性疼痛与非神经性疼痛的波斯语版DN4(神经病理性疼痛4个问题)问卷的有效性和可靠性。

Validity and reliability of the persian (Farsi) version of the DN4 (Douleur Neuropathique 4 Questions) questionnaire for differential diagnosis of neuropathic from non-neuropathic pains.

作者信息

Madani Seyed Pezhman, Fateh Hamid R, Forogh Bijan, Fereshtehnejad Seyed-Mohammad, Ahadi Tannaz, Ghaboussi Pouya, Bouhassira Didier, Raissi Gholam Reza

机构信息

Physical Medicine and Rehabilitation Department, Tehran University of Medical Sciences (TUMS), Tehran, Iran.

出版信息

Pain Pract. 2014 Jun;14(5):427-36. doi: 10.1111/papr.12088. Epub 2013 Jun 14.

DOI:10.1111/papr.12088
PMID:23763722
Abstract

The aim of our study was translation and assessment of validity and reliability of the Persian version of DN4 questionnaire. The goal was to fill the gap caused by the absence of a validated instrument in Persian to facilitate discrimination of neuropathic pain. In this study, the adaptation and validation of the questionnaire was carried out in 4 steps, including translation, retranslation, semantic, and literal assessments, and a pilot study for practicability and potential perception difficulties of the final Persian version on 45 patient samples. The questionnaire validation performed on 175 patients, 112 (64%) females with the mean age of 52.53 (SD = 14.98) ranging from 22 to 87 years of age with neuropathic (N = 86) and non-neuropathic pain (NNP) (N = 89). Sensitivity, specificity, and Youden Index in cut-off point ≥ 4 were 90%, 95%, and 0.85, respectively, which are noteworthy findings among other validation studies. The Cronbach's alpha coefficient of the whole questionnaire was 0.852. Inter-rater agreement and test-retest reliability were significant intraclass coefficient (ICC = 0.957 and ICC = 0.918, respectively). The Persian version of DN4 questionnaire is a reliable, valid, feasible, and easily administered tool for precise discrimination neuropathic pain from NNP in Farsi. The characteristics of this test can assist practitioner to diagnose neuropathic pain accurately for both clinical and research purposes.

摘要

我们研究的目的是翻译并评估波斯语版DN4问卷的有效性和可靠性。目标是填补因缺乏波斯语版有效工具而导致的空白,以促进神经性疼痛的鉴别。在本研究中,问卷的改编和验证分4个步骤进行,包括翻译、回译、语义和字面评估,以及对45例患者样本进行最终波斯语版的实用性和潜在理解困难的预试验。对175例患者进行了问卷验证,其中112例(64%)为女性,平均年龄52.53岁(标准差=14.98),年龄范围为22至87岁,患有神经性疼痛(N=86)和非神经性疼痛(NNP)(N=89)。在截断点≥4时,敏感性、特异性和尤登指数分别为90%、95%和0.85,这些是其他验证研究中值得注意的发现。整个问卷的克朗巴哈α系数为0.852。评分者间一致性和重测信度的组内相关系数显著(分别为ICC=0.957和ICC=0.918)。波斯语版DN4问卷是一种可靠、有效、可行且易于实施的工具,可用于准确鉴别波斯语患者的神经性疼痛和非神经性疼痛。该测试的特点可帮助从业者出于临床和研究目的准确诊断神经性疼痛。

相似文献

1
Validity and reliability of the persian (Farsi) version of the DN4 (Douleur Neuropathique 4 Questions) questionnaire for differential diagnosis of neuropathic from non-neuropathic pains.用于区分神经性疼痛与非神经性疼痛的波斯语版DN4(神经病理性疼痛4个问题)问卷的有效性和可靠性。
Pain Pract. 2014 Jun;14(5):427-36. doi: 10.1111/papr.12088. Epub 2013 Jun 14.
2
Validity and reliability of the Arabic adapted version of the DN4 questionnaire (Douleur Neuropathique 4 Questions) for differential diagnosis of pain syndromes with a neuropathic or somatic component.阿拉伯语适应版 DN4 问卷(DN4 问卷,即 4 个问题神经性疼痛问卷)用于鉴别诊断具有神经性或躯体性成分的疼痛综合征的有效性和可靠性。
Pain Pract. 2011 Mar-Apr;11(2):139-47. doi: 10.1111/j.1533-2500.2010.00399.x.
3
Translation to Portuguese and validation of the Douleur Neuropathique 4 questionnaire.翻译为葡萄牙语并验证《神经病理性疼痛 4 问卷》。
J Pain. 2010 May;11(5):484-90. doi: 10.1016/j.jpain.2009.09.014. Epub 2009 Dec 16.
4
Turkish version of the painDETECT questionnaire in the assessment of neuropathic pain: a validity and reliability study.疼痛 DETECT 问卷土耳其语版用于评估神经性疼痛的有效性和可靠性研究。
Pain Med. 2013 Dec;14(12):1933-43. doi: 10.1111/pme.12222. Epub 2013 Aug 7.
5
A comparison of the DN4 and LANSS questionnaires in the assessment of neuropathic pain: validity and reliability of the Turkish version of DN4.DN4 与 LANSS 问卷在神经性疼痛评估中的比较:DN4 土耳其语版本的有效性和可靠性。
J Pain. 2010 Nov;11(11):1129-35. doi: 10.1016/j.jpain.2010.02.003. Epub 2010 Apr 24.
6
Validation of a New Arabic Version of the Neuropathic Pain Diagnostic Questionnaire (DN4).新版阿拉伯语版神经性疼痛诊断问卷(DN4)的验证
Pain Pract. 2017 Jan;17(1):78-87. doi: 10.1111/papr.12419. Epub 2016 Feb 20.
7
Diagnostic accuracy of two questionnaires for the detection of neuropathic pain in the Spanish population.两种问卷在西班牙人群中检测神经性疼痛的诊断准确性。
Eur J Pain. 2014 Jan;18(1):101-9. doi: 10.1002/j.1532-2149.2013.00350.x. Epub 2013 Jun 17.
8
Neuropathic Pain Questionnaire and Neuropathic Pain Questionnaire-Short Form: Translation, Reliability, and Validation Study of the Turkish Version.神经性疼痛问卷和神经性疼痛问卷简表:土耳其语版本的翻译、信度和效度研究
Turk Neurosurg. 2019;29(5):683-688. doi: 10.5137/1019-5149.JTN.25466-18.1.
9
Validity and reliability of the Spanish version of the DN4 (Douleur Neuropathique 4 questions) questionnaire for differential diagnosis of pain syndromes associated to a neuropathic or somatic component.用于鉴别与神经病理性或躯体性成分相关疼痛综合征的西班牙文版DN4(神经病理性疼痛4个问题)问卷的效度和信度
Health Qual Life Outcomes. 2007 Dec 4;5:66. doi: 10.1186/1477-7525-5-66.
10
Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy.验证 DN4 作为一种筛查工具用于诊断痛性糖尿病多发性神经病中的神经性疼痛。
Diabet Med. 2012 May;29(5):578-85. doi: 10.1111/j.1464-5491.2011.03500.x.

引用本文的文献

1
Effect of perceived injustice-targeted pain neuroscience education compared with biomedically focused education in breast cancer survivors: a study protocol for a multicentre randomised controlled trial (BCS-PI trial).基于感知不公的靶向疼痛神经科学教育对比以生物医学为重点的教育对乳腺癌幸存者的影响:一项多中心随机对照试验(BCS-PI 试验)的研究方案。
BMJ Open. 2024 Jan 17;14(1):e075779. doi: 10.1136/bmjopen-2023-075779.
2
Nepalese version of Douleur Neuropathique 4 (DN4) questionnaire for detection of neuropathic pain signs and symptoms: Translation and psychometric properties.尼泊尔版的疼痛神经病理性问卷 4(DN4)用于检测神经病理性疼痛的体征和症状:翻译和心理测量特性。
PLoS One. 2023 Jul 17;18(7):e0287737. doi: 10.1371/journal.pone.0287737. eCollection 2023.
3
Possible Neuropathic Pain in Clinical Practice-Review on Selected Diagnostic Tools and Its Further Challenges.临床实践中可能存在的神经性疼痛——关于选定诊断工具及其进一步挑战的综述
Diagnostics (Basel). 2022 Dec 29;13(1):108. doi: 10.3390/diagnostics13010108.
4
Psychometric Properties of the Persian Version of the ID-Pain Questionnaire.ID疼痛问卷波斯语版本的心理测量学特性。
Arch Bone Jt Surg. 2022 Feb;10(2):213-218. doi: 10.22038/ABJS.2021.53348.2647.
5
Validation of Complete Hindi Version of Douleur Neuropathique 4 Questionnaire for Assessment of Neuropathic Pain.用于评估神经性疼痛的《神经病理性疼痛4问卷》印地语完整版的验证
Indian J Palliat Care. 2021 Apr-Jun;27(2):257-263. doi: 10.25259/IJPC_340_20. Epub 2021 Aug 12.
6
Role of interdigital sensory nerve conduction study as a noninvasive approach for early diagnosis of diabetic peripheral neuropathy.指间感觉神经传导研究作为糖尿病周围神经病变早期诊断的非侵入性方法的作用。
J Diabetes Metab Disord. 2021 Feb 15;20(1):71-75. doi: 10.1007/s40200-020-00710-1. eCollection 2021 Jun.
7
Assessment of diagnostic criteria for the identification of central sensitization in patients with osteoarthritis pain: Results from a Delphi survey.评估用于识别骨关节炎疼痛患者中枢敏化的诊断标准:德尔菲调查结果。
Medicine (Baltimore). 2020 Dec 24;99(52):e23470. doi: 10.1097/MD.0000000000023470.
8
Psychometric features of Neuropathic Pain Symptom Inventory in Iranian people with Parkinson's disease.帕金森病伊朗患者的神经性疼痛症状量表的心理计量学特征。
Neurol Sci. 2021 Aug;42(8):3233-3239. doi: 10.1007/s10072-020-04941-1. Epub 2020 Nov 26.
9
Validity and Reliability of Short-Form McGill Pain Questionnaire-2 (SF-MPQ-2) in Iranian People with Parkinson's Disease.简式麦吉尔疼痛问卷-2(SF-MPQ-2)在伊朗帕金森病患者中的效度和信度
Parkinsons Dis. 2020 Aug 18;2020:2793945. doi: 10.1155/2020/2793945. eCollection 2020.
10
The effects of botulinum toxin type A injection on pain symptoms, quality of life, and sleep quality of patients with diabetic neuropathy: A randomized double-blind clinical trial.A型肉毒杆菌毒素注射对糖尿病性神经病变患者疼痛症状、生活质量及睡眠质量的影响:一项随机双盲临床试验。
Iran J Neurol. 2019 Jul 6;18(3):99-107.